Analytical Data
-
Gene name
LONRF2
- Application
-
Alternative Names
LONRF2; LON peptidase N-terminal domain and RING finger protein 2; Neuroblastoma apoptosis-related protease; RING finger protein 192
-
Species
Human
-
Source
E. coli
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q1L5Z9
-
Expression Region
S2-N754
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZBTB7B, also known as ZBTB7 or RIZ1, is a member of the zinc finger and BTB (Bric à Brac, Tramtrack, and Broad Complex) domain-containing protein family, which plays significant roles in various biological processes, including cell differentiation, proliferation, and apoptosis. Research on ZBTB7B has gained prominence due to its involvement in cancer biology, particularly its potential as a tumor suppressor. It has been implicated in the regulation of several key pathways, including those involved in immune response and cellular transformation. Studies have shown that ZBTB7B exerts its effects by influencing gene expression, directly interacting with chromatin, and modulating transcriptional networks. Moreover, aberrations in ZBTB7B function or expression have been linked to several malignancies, thus spurring interest in its potential as a therapeutic target. The recombination and characterization of ZBTB7B protein could provide crucial insights into its structure-function relationships and facilitate the development of targeted interventions in cancer treatment. By understanding the biochemical properties and interaction dynamics of ZBTB7B, researchers aim to elucidate its role in tumorigenesis and explore its application in novel therapeutic strategies.
